Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-24 @ 5:32 PM
NCT ID:
NCT03481868
Eligibility Criteria:
Inclusion Criteria:
* Patient newly diagnosed for Chronic Myeloid Leukemia in chronic phase
* Patient older than 18 years old
* Patient who received no treatment for CML at the time of sampling on D0
* Intention of prescription with first-line treatment with TKI only
* Choice of first-line CML treatment by TKI only
* Patient having signed an informed consent
* Patient with a social security system
Exclusion Criteria:
* Contra-indication to the use of TKI
* Probability of poor compliance during treatment
* Patients already treated for CML
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03481868
Study Brief:
Protocol Section:
NCT03481868